Isolagen Inc. Completes Registered Direct Offering of Common Stock
August 23 2007 - 9:00AM
PR Newswire (US)
EXTON, Pa., Aug. 23 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc.
(AMEX:ILE) today announced that it completed its previously
announced registered direct offering of approximately 6.76 million
shares of common stock at a price of $2.04 per share to
institutional investors for gross proceeds of approximately $13.8
million. The shares were offered under an effective shelf
registration statement previously filed with the Securities and
Exchange Commission. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy these
securities, nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. About Isolagen,
Inc. Isolagen(TM), Inc. (AMEX:ILE) is an aesthetic and therapeutic
company committed to developing and commercializing scientific
advances and innovative technologies. The company's technology
platform includes the Isolagen Process(TM), a cell processing
system for skin and tissue rejuvenation which is currently in
clinical development for a broad range of aesthetic and therapeutic
applications including wrinkles, acne scars, burns and periodontal
disease. Isolagen also commercializes a scientifically-advanced
line of skincare systems through its majority-owned subsidiary,
Agera(R) Laboratories, Inc. For additional information, please
visit http://www.isolagen.com/. DATASOURCE: Isolagen(TM), Inc.
CONTACT: Media, Mike Beyer of Sam Brown Inc., +1-773-463-4211, ,
for Isolagen, Inc.; Investors, Charles Huiner of Isolagen, Inc.,
+1-484-713-6200, Web site: http://www.isolagen.com/
Copyright
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jul 2023 to Jul 2024